Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

63921 Press Releases
DateTitleCompany
30 Mar 12 Amyris to Participate in Investor Conferences Amyris Inc.,
Published by
Business Wire
30 Mar 12 Asuragen Awarded $6.8 Million Commercialization Award from the Cancer Prevention and Research Institute of Texas Asuragen Inc.,
Published by
Business Wire
30 Mar 12 UnitedHealthcare and Feinberg School of Medicine Launch New Plain-Language Initiative UnitedHealthcare,
Published by
Business Wire
30 Mar 12 Transgenomic, Inc. Announces Presentation of Results from 448-Gene NuclearMitome Test in 78 Patients at the 2012 Annual Meeting of the American College of Medical Genetics Transgenomic Inc.,
Published by
Business Wire
30 Mar 12 Bayer’s Xarelto® (rivaroxaban) Gains NICE Recommendation for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation Bayer HealthCare
30 Mar 12 medeConnect appoints new Research Manager medeConnect
30 Mar 12 Fujifilm Unveils Aspire CRm Digital Mammography System FUJIFILM MEDICAL SYSTEMS INC.,
Published by
PR Newswire
30 Mar 12 Research and Markets: The US Pharmaceutical Market Outlook to 2016 - Evolving Opportunities in the Biologics Segment Research and Markets,
Published by
Business Wire
30 Mar 12 Research and Markets: China Pharmaceutical Industry Research and Forecast to 2016 - Industry Grew by 19.54% in 2011 Research and Markets,
Published by
Business Wire
30 Mar 12 Research and Markets: Bydureon FDA Approval: Physician Opinion Following January 27th 2012 Decision Research and Markets,
Published by
Business Wire
30 Mar 12 Research and Markets: Analysis of European Biosimilars Market Research and Markets,
Published by
Business Wire
30 Mar 12 AlphaCore Pharma Initiates ACP-501 (rhLCAT) Clinical Trial in Patients with Coronary Artery Disease AlphaCore Pharma,
Published by
Business Wire
30 Mar 12 ImmunoGen, Inc. Announces Initiation of Phase II Evaluation of Its IMGN901 Product Candidate ImmunoGen Inc.,
Published by
Business Wire
30 Mar 12 ImmunoGen, Inc. Announces Conference Call at 8:00 am ET March 30, 2012 to Discuss Today’s Favorable Announcements about Trastuzumab Emtansine (T-DM1) and about IMGN901 ImmunoGen Inc.,
Published by
Business Wire
30 Mar 12 NICE recommends new treatment option for people with common heart condition NICE
30 Mar 12 Genentech’s Trastuzumab Emtansine (T-DM1) Showed Positive Phase III Results In HER2-Positive Metastatic Breast Cancer Genentech,
Published by
Business Wire
30 Mar 12 Fujifilm Holdings Completes Acquisition of SonoSite FUJIFILM Holdings Corporation,
Published by
Business Wire
30 Mar 12 US District Court Finds SEROQUEL XR Formulation Patent Valid and Infringed AstraZeneca,
Published by
Business Wire
30 Mar 12 State Institute Awards More Than $81 Million to Support Cancer Drug Discovery and Development in Texas Cancer Research and Prevention Institute of Texas,
Published by
Business Wire
30 Mar 12 Hercules Technology Growth Capital Appoints Jessica Baron as Chief Financial Officer Hercules Technology Growth Capital Inc.,
Published by
Business Wire
30 Mar 12 BIO Testifies on Importance of Timely Passage of BsUFA and PDUFA Biotechnology Industry Organization,
Published by
Business Wire
30 Mar 12 ImmunoGen, Inc. Announces Positive Results in Trastuzumab Emtansine (T-DM1) EMILIA Phase III Trial ImmunoGen Inc.,
Published by
Business Wire
30 Mar 12 The Military’s Commitment to Biofuels and Alternative Energy Is a National Security Imperative, BIO Says Biotechnology Industry Organization,
Published by
Business Wire
30 Mar 12 Bio-Path Holdings Engages PondelWilkinson for Retail Investor Relations Program Bio-Path Holdings Inc.,
Published by
Business Wire
30 Mar 12 Research and Markets: Zambia Pharmaceuticals and Healthcare Report Q2 2012 - The Zambian Government Announced In December 2011 That It Plans To Hire and Train 2,500 Staff Research and Markets,
Published by
Business Wire
30 Mar 12 Lantheus Medical Imaging to Host Fourth Quarter/2011 Conference Call on April 5, 2012 at 4:00 p.m. Eastern Time Lantheus Medical Imaging Inc.,
Published by
Business Wire
30 Mar 12 Interleukin Genetics Reports Fourth Quarter and Year End 2011 Financial Results Interleukin Genetics,
Published by
Business Wire
29 Mar 12 Pernix Therapeutics to Present at the 11th Annual Needham Healthcare Conference Pernix Therapeutics Holdings Inc.,
Published by
Business Wire
29 Mar 12 Dementia Patients Still Facing a ‘Postcode Lottery’ on Treatment, Says Stephen McPartland MP Stephen McPartland MP,
Published by
Business Wire
29 Mar 12 Asfotase Alfa Significantly Decreased TNSALP Substrates and Improved 6-Minute Walk Test Results in Adolescents and Adults with Hypophosphatasia (HPP) Alexion Pharmaceuticals Inc.,
Published by
Business Wire
Advertising